Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare TSE:CDM NYSE:CVC CVE:IBT NYSE:JPS TSE:KIT On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCDM7591 (CDM.TO)C$0.00C$10.45▼C$20.14N/AN/A16,310 shsN/ACVCCablevision Systems$34.87$0.00$21.37▼$34.91N/AN/A2.99 million shsN/AIBTIBEX TechnologiesC$1.44C$1.44C$0.75▼C$1.45C$35.54M-0.0568,888 shs200 shsJPSNuveen Preferred Securities Income Fund$6.21$6.09$5.80▼$7.71N/AN/A612,150 shs3.00 million shsKITKits EyecareC$0.00C$0.00▼C$0.00N/AN/AN/AN/AThe 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCVCCablevision Systems0.00%0.00%0.00%0.00%0.00%IBTIBEX Technologies0.00%0.00%0.00%0.00%0.00%JPSNuveen Preferred Securities Income Fund0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCDM7591 (CDM.TO)N/AN/AN/AN/AN/AN/AN/AN/ACVCCablevision SystemsN/AN/AN/AN/AN/AN/AN/AN/AIBTIBEX TechnologiesN/AN/AN/AN/AN/AN/AN/AN/AJPSNuveen Preferred Securities Income FundN/AN/AN/AN/AN/AN/AN/AN/AKITKits EyecareN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCDM7591 (CDM.TO) 0.00N/AN/AN/ACVCCablevision Systems 0.00N/AN/AN/AIBTIBEX Technologies 0.00N/AN/AN/AJPSNuveen Preferred Securities Income Fund 0.00N/AN/AN/AKITKits Eyecare 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCDM7591 (CDM.TO)N/AN/AN/AN/AN/AN/ACVCCablevision SystemsN/AN/AN/AN/AN/AN/AIBTIBEX TechnologiesC$5.77M6.15C$0.92 per share1.56C$0.58 per share2.48JPSNuveen Preferred Securities Income Fund-$132.61MN/AN/AN/AN/AN/AKITKits EyecareN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCDM7591 (CDM.TO)N/AN/A0.00N/AN/AN/AN/AN/AN/ACVCCablevision SystemsN/A$0.7347.77∞N/AN/AN/AN/AN/AIBTIBEX TechnologiesC$3.10MC$0.1211.52∞N/A53.78%21.95%6.42%N/AJPSNuveen Preferred Securities Income FundN/AN/A0.00∞N/AN/AN/AN/AN/AKITKits EyecareN/AN/A0.00N/AN/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCDM7591 (CDM.TO)N/AN/AN/AN/AN/ACVCCablevision Systems$0.150.43%N/A20.55%N/AIBTIBEX TechnologiesN/A3.11%N/AN/AN/AJPSNuveen Preferred Securities Income Fund$0.518.21%N/AN/AN/AKITKits EyecareN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCDM7591 (CDM.TO)N/AN/AN/ACVCCablevision SystemsN/AN/AN/AIBTIBEX Technologies11.066.244.93JPSNuveen Preferred Securities Income FundN/AN/AN/AKITKits EyecareN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCDM7591 (CDM.TO)N/ACVCCablevision SystemsN/AIBTIBEX Technologies19.05%JPSNuveen Preferred Securities Income FundN/AKITKits EyecareN/AInsider OwnershipCompanyInsider OwnershipCDM7591 (CDM.TO)N/ACVCCablevision SystemsN/AIBTIBEX Technologies25.36%JPSNuveen Preferred Securities Income FundN/AKITKits EyecareN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCDM7591 (CDM.TO)N/AN/AN/ANot OptionableCVCCablevision SystemsN/AN/AN/ANot OptionableIBTIBEX TechnologiesN/A24.68 millionN/ANot OptionableJPSNuveen Preferred Securities Income FundN/AN/AN/ANot OptionableKITKits EyecareN/AN/AN/AN/AIBT, CDM, KIT, JPS, and CVC HeadlinesRecent News About These CompaniesFY2025 EPS Estimates for Kits Eyecare Lifted by Roth CapitalJuly 12 at 2:15 AM | americanbankingnews.comRoth Capital Estimates Kits Eyecare's Q2 Earnings (TSE:KIT)July 11 at 2:15 AM | americanbankingnews.comKits Eyecare Ltd Ordinary Shares Financials - MorningstarJuly 10, 2025 | morningstar.comMKITS Eyecare Reports Preliminary Second Quarter 2025 ResultsJuly 7, 2025 | finance.yahoo.comHaywood raises price target on KITS Eyecare to $21.00July 4, 2025 | cantechletter.comCKITS Announces Voting Results from 2025 Annual General Meeting of ShareholdersJune 4, 2025 | finance.yahoo.comKits Eyecare: Top 10 Undervalued Retail - Cyclical Industry Stocks (KITS)June 3, 2025 | theglobeandmail.comKits, Southern Cross at 52-Week Highs on NewsMay 30, 2025 | baystreet.caKits Eyecare Gets TSX Green Light to Launch 5% Share Buyback ProgramMay 30, 2025 | marketwatch.comAnalyst ups his price target on KITS EyecareMay 28, 2025 | cantechletter.comCeCommerce Company KITS Eyecare Reports Record First Quarter 2025 Results, Q1 Revenue Up 34% Year-Over-Year to Record $46.6 MillionMay 10, 2025 | bctechnology.comBVancouver's Kits Eyecare grows sales by a third to record $46.6MMay 7, 2025 | biv.comBKits Eyecare Reports Record Q1 Revenue and ProfitMay 7, 2025 | retail-insider.comRGreystone Capital Q1 2025 Letter To ClientsMay 2, 2025 | seekingalpha.comKITS Eyecare: Strong Moat, Expanding Growth Runway, And A Prime Acquisition TargetMay 2, 2025 | seekingalpha.comKITS Expands Vision Care Partnership with Medavie Blue CrossApril 16, 2025 | finance.yahoo.comKits Eyecare Reports Preliminary Q1 Revenues Of $46.6 MillionApril 8, 2025 | thedeepdive.caTKITS Eyecare’s Visionary Approach Fuels Remarkable 42% Revenue Surge in Q4 2024April 4, 2025 | markets.businessinsider.com3 TSX Stocks Estimated To Be Trading At Discounts Of Up To 49.7%March 26, 2025 | finance.yahoo.comStocks in play: Kits Eyecare Ltd,March 25, 2025 | ca.finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeIBT, CDM, KIT, JPS, and CVC Company Descriptions7591 (CDM.TO) TSE:CDMCablevision Systems NYSE:CVCCablevision Systems Corporation (Cablevision), through its subsidiary, CSC Holdings, LLC (CSC Holdings), operates cable operations business in the United States. The Company operates in three segments: Cable, Lightpath and Other. The Company's Cable segment offers Cable television service, which delivers multiple channels of video programming to subscribers who pay a monthly fee for the services they receive. The Company operates Lightpath segmeny, through its subsidiary, Cablevision Lightpath, Inc. (Lightpath), which provides Ethernet-based data, Internet, voice and video transport and managed services to the business market in the New York metropolitan area. Lightpath also provides managed information technology services to businesses, including hosted voice services, managed wireless fidelity, managed desktop and server backup, and managed collaboration services. The Other segment operations consist of the operations of Newsday, News 12 Networks and Cablevision Media Sales.IBEX Technologies CVE:IBTC$1.44 0.00 (0.00%) As of 04/5/2024IBEX Technologies Inc., through its subsidiaries, manufactures and markets enzymes for biomedical use in Canada, the United States, Germany, the United Kingdom, and internationally. It offers a portfolio of recombinant glycosaminoglycan lyases, including Heparinase I, Heparinase II, Heparinase III, Chondroitinase AC, and Chondroitinase B; collagen ELISAs for the study of synthesis and degradation of connective tissue components; collagen antibodies; and diamine oxidase liquid. The company also manufactures and markets a range of arthritis assays, which are used in osteoarthritis research. In addition, it provides lyophilization services for making disposable medical device components; and custom fermentation and contract manufacturing services. It serves manufacturers of medical devices, quality control labs, low molecular weight heparin manufacturers, and academic research institutions. IBEX Technologies Inc. was incorporated in 1972 and is based in Montreal, Canada.Nuveen Preferred Securities Income Fund NYSE:JPSNuveen Preferred Securities Income Fund is a closed-ended fixed income mutual fund launched by Nuveen Investments, Inc. The fund is co-managed by Nuveen Fund Advisors LLC and Spectrum Asset Management, Inc. It invests in the fixed income markets of the United States. The fund primarily invests in investment grade preferred debt securities, convertible debt securities, and convertible preferred securities that are rated BBB/Baa or better by S&P, Moody's, or Fitch. It was formerly known as Nuveen Quality Preferred Income Fund 2. Nuveen Preferred Securities Income Fund was formed on June 24, 2002 and is domiciled in the United States.Kits Eyecare TSE:KIT More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Insider Selling Hits Market Leaders—Should You Be Worried? MP Materials Stock Booms on New Government Positioning MarketBeat Week in Review – 07/07 - 07/11 How Texas Roadhouse Is Winning in a Changing Consumer Market Power Solutions International Poised for 75% Upside The Meteoric Rise of Rocket Lab: A Space Stock to Watch Meta and Autonomous Advertising: The Stock's Next Big Tailwind? 3 Catalysts Converge on Intel Ahead of a Critical Earnings Report Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.